2010分子影像市场分析报告 Molecular Imaging Markets.pdf
《2010分子影像市场分析报告 Molecular Imaging Markets.pdf》由会员分享,可在线阅读,更多相关《2010分子影像市场分析报告 Molecular Imaging Markets.pdf(138页珍藏版)》请在三一文库上搜索。
1、 Molecular Imaging Markets Rures adquireret umbraculi, etiam tremulus matrimonii libere senesceret app July 2010 Kalorama Information A division of MarketR 38 East 29th Street Sixth Floor New York, New York 10016 212.807 .2660 t 800.298.5603 t 212.807 .2676 f MOLECULAR IMAGING A MARKET INTELLIGENCE
2、 ANALYSIS OF MARKET OPPORTUNITIES IN MOLECULAR IMAGING JULY 2010 A KALORAMA INFORMATION MARKET INTELLIGENCE REPORT Medical Imaging Markets: Molecular Imaging has been prepared by Kalorama Information. We serve business and industrial clients worldwide with a complete line of information services and
3、 research publications. Kalorama Information Market Intelligence Reports are specifically designed to aid the action-oriented executive by providing a thorough presentation of essential data and concise analysis. Editor: Joseph A. Constance Author: Joseph A. Constance Publication Date: July 2010 COP
4、YRIGHT 2010 Kalorama Information a division of MarketR, Inc. TABLE OF CONTENTS 1.0 Executive Summary 1 1.1 Molecular Basis of Cell Function 1 1.2 Driving Healthcare 1 1.3 Two Components 2 1.4 Key Modalities 4 1.5 World Market Summary 6 1.5.1 Market Drivers and Challenges 6 1.5.2 Growth Analysis 7 1.
5、6 Methodology 9 2.0 Introduction 11 2.1 Definition 11 2.1.1 For Diagnosis 13 2.1.1.1 Molecular Agents 15 2.2 New Direction for Medicine 16 2.3 Modalities and Applications 17 2.3.1 Nuclear Medicine 17 2.3.1.1 PET 20 2.3.1.2 SPECT and Gamma Cameras 23 2.3.2 CT 26 2.3.3 MRI 28 2.3.4 Ultrasound 30 2.3.5
6、 Fusion Imaging 32 2.3.5.1 PET/CT 34 2.3.5.2 SPECT/CT 36 2.4 Optical Imaging 39 2.5 Drivers 41 2.6 Issues and Challenges 43 2.7 Health Care Reform 48 3.0 Research with Potential 51 3.1 Heart Failure 51 3.2 Breast Biopsies 52 3.3 Treating Thyroid Cancer 53 3.4 Molecular Events 55 3.5 Nanoparticle Pla
7、tform 55 3.6 Detecting Circulating Progenitor Cells 57 3.7 Molecular Level Tumor Activity 57 3.8 Brain Cell Inflammatory Response 58 3.9 Hybrid Scanner 59 3.10 Semiconductor-Based PET Scanner 60 3.11 PET Scanning Coverage 61 3.12 Motion-Frozen Technology 62 3.13 Recurring Prostate Cancer 63 3.14 Bon
8、e Imaging Alternatives 65 3.15 New Perfusion Tracer 66 4.0 Markets 69 4.1 Overview 69 4.2 Procedures 71 4.3 Forecasts 78 4.3.1 PET (US/World/Installed Base) 78 4.3.2 SPECT-Gamma Camera Systems (US/World/Installed Base) 82 4.3.3 MRI (US/World) 86 4.3.4 CT (US/World) 88 4.3.5 Ultrasound (US/World) 90
9、4.3.6 Fusion Imaging 92 4.3.7 Optical Imaging 97 5.0 Corporate Profiles 99 5.1 Advanced Biomarker Technologies 99 5.2 Agilent Technologies 100 5.3 Avid Radiopharmaceuticals Inc. 102 5.4 Bioscan 103 5.5 Capintec Inc. 105 5.6 Cardinal Health 106 5.7 Clinical Data Inc. 107 5.8 Digirad Corp. 108 5.9 Dil
10、on Diagnostics 109 5.10 Gamma Medica-Ideas Inc. 110 5.11 GE Healthcare 112 5.12 Hitachi Medical Systems America Inc. 115 5.13 MIR Preclinical Services 117 5.14 OptoSonics Inc. 119 5.15 Philips Healthcare 121 5.16 PhotoDetection Systems Inc. 123 5.17 Positron Corp. 124 5.18 Shimadzu Corp. 125 5.19 Si
11、emens Healthcare 126 5.20 Spectrum Dynamics Ltd. 128 5.21 Toshiba America Medical Systems 129 5.22 UltraSPECT Ltd. 130 5.23 VisEn Medical Inc. 132 5.24 Zecotek Photonics Inc. 133 LIST OF EXHIBITS Exhibit 1: World Market for Molecular Imaging 8 Exhibit 2: Key Liquid Radionuclides 19 Exhibit 3: Worldw
12、ide SPECT Procedures 73 Exhibit 4: US SPECT Procedures 74 Exhibit 5: Worldwide PET Procedures 75 Exhibit 6: US PET Procedures 76 Exhibit 7: Worldwide Molecular CT Procedures 77 Exhibit 8: Worldwide Molecular PET Procedures 77 Exhibit 9: World Medical Market for PET Systems 79 Exhibit 10: US Medical
13、Market for PET Systems 80 Exhibit 11: World Medical Market for PET Systems 80 Exhibit 12: US Medical Market for PET Systems 81 Exhibit 13: Worldwide Medical PET Installed Base 82 Exhibit 14: World Medical Market for SPECT Systems 83 Exhibit 15: US Medical Market for SPECT Systems 84 Exhibit 16: Worl
14、d Medical Market for SPECT Systems 84 Exhibit 17: US Medical Market for SPECT Systems 84 Exhibit 18: Worldwide Medical SPECT Installed Base 86 Exhibit 19: World Medical Market for MRI Molecular Imaging Systems 88 Exhibit 20: US Medical Market for MRI Molecular Imaging Systems 88 Exhibit 21: World Me
15、dical Market for CT Molecular Imaging Systems 89 Exhibit 22: US Medical Market for CT Molecular Imaging Systems 90 Exhibit 23: World Medical Market for Ultrasound Molecular Imaging Systems 91 Exhibit 24: US Medical Market for Ultrasound Molecular Imaging Systems 92 Exhibit 25: World Medical Market f
16、or PET/CT Imaging Systems 93 Exhibit 26: US Medical Market for PET/CT Imaging Systems 94 Exhibit 27: World Medical Market for SPECT/CT Imaging Systems 96 Exhibit 28: US Medical Market for SPECT/CT Imaging Systems 96 1.0 Executive Summary 1.1 Molecular Basis of Cell Function Traditional medical imagi
17、ng techniques use minimally-invasive approaches that anatomically image the internal organs of the body in order to diagnose disease. Molecular imaging evolved from anatomical medical imaging. Advances in molecular biology improved the understanding of many diseases and natural processes and helped
18、fuel the development of imaging techniques that diagnose disease on the molecular level - based on the interaction of proteins and other cellular-level compounds. As scientists learn more about the molecular basis of disease, one research priority has been to develop imaging modalities that assess t
19、he molecular basis of cell function and dysfunction. Molecular imaging techniques are based on technologies that have an intrinsically high resolution, which makes it possible to detect low concentrations of target biomolecules found in tissue. Molecular imaging techniques include nuclear medicine i
20、maging - positron emission tomography (PET) and single photon emission computed tomography (SPECT) and combination PET/CT and SPECT/CT techniques as well as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT) imaging that are used with molecular imaging agents. Molecular imaging h
21、as evolved into a pilar of molecular medicine. It combines functional imaging with structural imaging so that specific in-vivo molecular processes can be identified and spatially pinpointed, often with the use of imaging contrast agents that bind to specific biological proteins. Molecular imaging is
22、 playing diagnostic and treatment roles as it enables physicians to pinpoint the locations of disease and track the progress of therapies. The same contrast agents used to highlight disease sites may even be able to carry drugs that can be selectively unleashed precisely where they are needed. 1.2 D
23、riving Health care Molecular imaging is a driving force in health care. The Human Genome Project yielded a wealth of information that is being used to map human biology. Science and Executive Summary 2 health care givers are learning how the human body functions, and how they can put this informatio
24、n to use. The FDA, the National Institutes of Health (NIH) and many international organizations have recognized the importance of using biomarkers and expanding the use of biomarkers in medicine substances that are indicators of a biological state. Molecular imaging derives information from a patien
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 2010分子影像市场分析报告 Molecular Imaging Markets 2010 分子 影像 市场分析 报告
链接地址:https://www.31doc.com/p-3727515.html